Released Products with Masimo SET technology: (Move mouse over instrument names to see pictures.) Welch Allyn Medical Products Corporate Headquarters 4341 State Street Road Skaneateles Falls, NY 13153-0220 USA Telephone: 1-800-535-6663 Fax: 315-685-4091 www.welchallyn.com Welch Allyn Protocol and Masimo Corp. Announce Anticipated Year-End Introduction of the Welch Allyn Protocol Micropaq Wireless Ambulatory Patient Monitor with Masimo SET Signal Extraction Pulse Oximetry Technology PORTLAND, Ore. & IRVINE, Calif.--Oct. 3, 2000--Welch Allyn Protocol, a leading supplier of patient monitoring technology, and Masimo Corp., the recognized market innovator in motion and low perfusion pulse oximetry, today announced continued progress towards the anticipated year-end launch of the Micropaq® wireless ambulatory monitor, the first Welch Allyn Protocol product to incorporate Masimo SET® technology. Said Jim Welch, VP/General Manager of the Welch Allyn Protocol Flexible Monitoring® Business Unit, "The Micropaq has generated unprecedented clinician and market excitement. It creates an entirely new class of portable, wearable vital signs monitors that contribute to positive patient outcomes and caregiver productivity in lower cost settings in the hospital. The clinical effectiveness of the Micropaq depends upon pulse oximetry technology that offers both low power consumption and motion tolerance--features that only Masimo can offer us today." "Clinicians associate high-performance, motion tolerant pulse oximetry with the Masimo brand name,'' said Robert F. Adrion, President & CEO of Welch Allyn Protocol. "We will continue to work closely with Masimo to offer Masimo SET oximetry solutions in other monitors as they become available." "We are pleased with our continuing relationship with Welch Allyn Protocol," stated Joe E. Kiani, President and CEO of Masimo Corp. "The need for a low power OEM board and clinically proven technology in motion and low perfusion environments made Masimo's MS-3L board a perfect fit for Micropaq." The Micropaq monitor, including ECG, heart rate and pulse oximetry, is currently pending FDA 510(k) market clearance. About Welch Allyn Protocol Welch Allyn Protocol, Inc. designs, manufactures and markets mission-critical flexible monitoring solutions that improve patient care and lower healthcare operating costs. Welch Allyn Protocol uses innovative computer and software technologies to provide vital patient data and connect clinicians with mobile patients via workstations, wireless devices and the Internet. Welch Allyn Protocol is a wholly owned subsidiary of Welch Allyn, Inc. and is based in Beaverton, Oregon. Its products are available in more than 90 countries around the world. Welch Allyn, Inc. was founded in 1915 and is today a leading manufacturer of innovative medical and dental diagnostic equipment and miniature precision lamps. Headquartered in Skaneateles Falls, New York, U.S.A., Welch Allyn, Inc. has more than 2,000 employees and numerous manufacturing, sales, and distribution facilities located throughout the world.